Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.
Roberto CaporaliFrancesco MaseduSaverio AlvaroPaolo AiròNorma BattafaranoClaudia FabianiFrancesco Paolo CantatoreGiorgio CarlinoVirginia D'AbroscaMicol FrassiBruno FredianiDaniela IaconoVasiliki LiakouliRoberta MaggioRita MulèIlenia PantanoImmacolata PreveteLuigi SinigagliaMarco ValentiOmbretta ViapianaPaola CiprianiRoberto GiacomelliPublished in: PLoS medicine (2019)
The trial is registered with EU Clinical Trials Register, EudraCT Number: 2012-005370-62 and with ClinicalTrial.gov, number NCT02236481.